8-K/A

VISTAGEN 8KA MAY 11 2011

Company: Vistagen Therapeutics, Inc.
Filed: August 12, 2011
Period of Report: May 11, 2011
Accession Number: 0001415889-11-000765

View Document ↗ View on SEC.gov ↗